“…Since the intestinal mucosa has high levels of adenosine deaminase (Ho et al, 1980), a prodrug of 1 that is protected from deamination during absorption may be a more effective oral agent. Substitution of the 2 /-or 5'-hydroxyl of adenosine is known to lead to compounds resistant to the action of adenosine deaminase (Shah et al, 1965;Bloch et al, 1967;Schaeffer et al, 1971;Hampton et al, 1972). In an earlier report we described the synthesis and evaluation of a series of di-and tri-esters of 1, which indicated that the 2' ,3 /-diacetate provided enhanced bioavailability and water solubility, whereas the 2',5 /-and 3',5 /-diacetates showed enhanced bioavailability with diminished aqueous solubility (Jones et al, 1991).…”